Post by PressRelease on Dec 21, 2023 2:05pm
New Press Release - Voyageur Pharmaceuticals Ltd Announces Deferred Share Unit (DSU) Grant to Directors
Comment by
biggdogg on Dec 21, 2023 2:39pm
Vote those bums out, has any of them invested a dime into Voy?
Comment by
WarrantOfficer on Dec 21, 2023 7:40pm
Trust is earned. IMO, management has not yet earned it. Investors whom paid for their shares are no doubt questioning if management deserves the DSU's. We are just coming off a year low SP of .035 Was the 2023 AGM zoomed? I did receive the voting proxies, read nothing about the AGM being zoomed.
Comment by
whitenorth72 on Dec 22, 2023 11:46am
Warrant officer will get my vote...
Comment by
lscfa on Jan 03, 2024 12:22am
Fullerene is no cost because it's a byproduct of Rain Cage's CO2 capture process but where is the vanadium coming from at no cost? "Voyageur is the only pharmaceutical company to have access to fullerene and vanadium at no sourcing cost because of its drug development agreement with Rain Cage."
Comment by
lscfa on Jan 03, 2024 1:23am
I did not realize Vanadium was polluting earth's atmosphere.... https://www.sciencedaily.com/releases/2017/12/171215121052.htm